Welcome to our dedicated page for Revvity news (Ticker: RVTY), a resource for investors and traders seeking the latest updates and insights on Revvity stock.
Revvity, Inc. reports developments for a global life sciences and diagnostics business that provides health science solutions, technologies, expertise and services across workflows from discovery and development to detection and diagnosis. Company updates center on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and Signals software for pharmaceutical, biotechnology, diagnostic laboratory, academic and government customers.
Recurring announcements include financial results and earnings calls, quarterly dividends, investor conference presentations, governance matters and product introductions. Recent product themes include Signals BioDesign for biologics construct design and research collaboration, Signals One platform integration, high-content imaging, multimode detection, sample preparation, screening and laboratory automation systems.
Summary not available.
Summary not available.
Summary not available.